Matthew R. Patterson

2011

In 2011, Matthew R. Patterson earned a total compensation of $1.4M as Former President at Amicus Therapeutics, a 151% increase compared to previous year.

Compensation breakdown

Option Awards$216,945
Salary$280,443
Stock Awards$360,500
Other$580,883
Total$1,438,771

Patterson received $580.9K in other compensation, accounting for 40% of the total pay in 2011.

Patterson also received $216.9K in option awards, $280.4K in salary and $360.5K in stock awards.

Rankings

In 2011, Matthew R. Patterson's compensation ranked 4,366th out of 10,747 executives tracked by ExecPay. In other words, Patterson earned more than 59.4% of executives.

ClassificationRankingPercentile
All
4,366
out of 10,747
59th
Division
Manufacturing
1,546
out of 3,960
61st
Major group
Chemicals And Allied Products
317
out of 1,033
69th
Industry group
Drugs
188
out of 781
76th
Industry
Pharmaceutical Preparations
146
out of 571
74th
Source: SEC filing on April 27, 2012.

Patterson's colleagues

We found six more compensation records of executives who worked with Matthew R. Patterson at Amicus Therapeutics in 2011.

2011

John Crowley

Amicus Therapeutics

Chief Executive Officer

2011

David Lockhart

Amicus Therapeutics

Chief Scientific Officer

2011

Pol Boudes

Amicus Therapeutics

Chief Medical Officer

2011

Bradley Campbell

Amicus Therapeutics

Chief Operating Officer

2011

Daphne Quimi

Amicus Therapeutics

Controller and Former Principal Financial Officer

2011

Mohan Ganesan

Amicus Therapeutics

Former Principal Financial Officer

You may also like